Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.800,01
-0,42%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Theravance Biopharma Inc (TBPH) Theravance Biopharma Inc (TBPH) Notizie

Theravance Biopharma Inc

TBPH
9,59
-0,14 (-1,44%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202412:00PRNUSTheravance Biopharma to Conduct Investor Meetings During the..
23/11/202400:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202412:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
14/11/202415:53EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202412:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:08EDGAR2Form 8-K - Current report
12/11/202422:05PRNUSTheravance Biopharma, Inc. Reports Third Quarter 2024..
24/10/202422:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
24/10/202412:00PRNUSTheravance Biopharma to Report Third Quarter 2024 Financial..
18/10/202415:00PRNUSTheravance Announces Publication of YUPELRI® (revefenacin)..
23/9/202412:05EDGAR2Form 8-K - Current report
10/9/202412:02EDGAR2Form 8-K - Current report
27/8/202412:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
23/8/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202422:16EDGAR2Form 8-K - Current report
05/8/202422:05PRNUSTheravance Biopharma, Inc. Reports Second Quarter 2024..
25/7/202412:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
22/7/202412:00PRNUSTheravance Biopharma to Report Second Quarter 2024 Financial..
13/7/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/5/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202412:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:13EDGAR2Form 8-K - Current report
13/5/202422:05PRNUSTheravance Biopharma, Inc. Reports First Quarter 2024..
11/5/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:15EDGAR2Form 8-K - Current report
09/5/202412:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
29/4/202412:00PRNUSTheravance Biopharma to Report First Quarter 2024 Financial..
10/4/202412:00PRNUSTheravance Biopharma, Inc. to Host Virtual Key Opinion..
26/2/202422:16EDGAR2Form 8-K - Current report
26/2/202422:05PRNUSTheravance Biopharma, Inc. Reports Fourth Quarter and Full..
23/2/202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 9,645 Min: 9,56 Max: 9,83
Chiusura: 9,73

La tua Cronologia

NASDAQ
TBPH
Theravance Biopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network